申请人:[en]ZENO MANAGEMENT, INC.
公开号:WO2023049199A1
公开(公告)日:2023-03-30
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including autoimmune diseases, inflammatory conditions and/or cancers.